Acutaas Chemicals LtdPharmaceuticalsINE00FF01025Consolidated₹3777.65-137.45 (-3.51%)
Valuation
Market Cap₹30.93K Cr
TTM PE81.85x
Forward PE75.89x
PEG3.00
Book Value₹226.87
P/B16.65x
TTM EPS₹46.15
Fwd EPS₹49.77
TTM Revenue₹1.47K Cr
TTM PAT₹376.21 Cr
TTM EBITDA₹524.34 Cr
TTM EBIT₹493.43 Cr
Last Qtr PAT₹123.14 Cr
Last Qtr EBITDA₹175.98 Cr
Last Qtr EBIT₹163.29 Cr
Profitability
ROE20.25%
ROCE27.49%
TTM NPM25.66%
TTM EBITDA %35.77%
Curr OPM27.86%
Last OPM22.62%
Curr NPM—
Last NPM—
Curr EPS₹15.29
Last EPS₹9.07
Balance sheet
Equity₹40.94 Cr
Reserve₹1.82K Cr
Total Debt₹15.14 Cr
D/E0.01x
Interest %0.83%
Curr Interest₹1.02 Cr
Price / range
Close₹3777.30
vs 52W High—
vs 52W Low—
MA50—
MA200—
Returns
1D-3.25%
1W+1.92%
1M+18.23%
3M+17.35%
6M+33.58%
1Y+234.05%
2Y+282.98%
3Y+557.26%
5Y—
Diwali+234.05%
Sector peers — Pharmaceuticals
CompanyCloseMkt CapTTM P/EROE
SUNPHARMA1773.40₹4.25L Cr38.8112.31%
DIVISLAB10037.50₹2.66L Cr91.0817.45%
TORNTPHARM4738.50₹1.60L Cr77.7711.42%
LAURUSLABS2323.80₹1.25L Cr93.6321.98%
ZYDUSLIFE1188.10₹1.20L Cr28.5315.79%
DRREDDY1374.00₹1.15L Cr40.897.11%
CIPLA1402.00₹1.13L Cr39.098.06%
MANKIND2537.90₹1.05L Cr46.7112.87%

Financial Results

Quarterly and yearly P&L · YoY % on Revenue, Total Income, Expenditure, EBITDA, EBIT, PBT, Net Profit and EPS

Standalone

16 lines · 6 periods
MetricSep-26Jun-26Mar-26Dec-25Sep-25FY25-26
Revenue433.05+41.9%329.67421.77390.86305.191,323.79
Other Income8.051.8014.556.348.9745.88
Total Income441.09+40.4%331.48436.32397.20314.161,369.67
Interest0.991.141.070.810.573.08
Expenditure-260.01-19.9%-227.57-250.46-246.49-216.88-876.90
PBDT000000
EBITDA183.34+89.8%113.06181.21154.2096.60483
Depreciation-9.31-9.82-8.83-9.02-7.72-33.03
EBIT174.03+95.8%103.24172.38145.1888.88449.97
PBT181.08+86.1%103.91185.86150.7197.28492.77
Tax-45.34-28.92-48.79-39.14-24.39-126.60
Equity40.9440.940000
OPM41.0531.3544.0738.5631.8836.00
Net Profit135.74+86.2%74.99137.07111.5772.89366.18
NPM30.7722.6232.5028.5423.8827.00
EPS16.58+86.3%9.0716.7413.638.9044.73

Yearly results

Last 6 financial years · YoY % vs previous FY

Yearly

17 lines · 4 years
MetricFY 25-26FY 24-25FY 23-24FY 22-23
Revenue1,323.79+33.7%989.84+44.0%687.58+11.5%616.73
Other Income45.8818.3413.794.32
Total Income1,369.67+35.9%1,008.17+43.7%701.37+12.9%621.05
Expenditure-876.90-10.4%-794.50-32.3%-600.51-18.0%-508.83
Interest-3.08-5.86-5.89-2.41
PBDT0000
EBITDA483+114.4%225.25+109.2%107.65-12.2%122.65
Depreciation-33.03-24.05-14.69-12.34
EBIT449.97+123.6%201.20+116.4%92.96-15.7%110.31
PBT492.77+130.7%213.58+209.0%69.11-38.4%112.23
Tax-126.60-54-25.43-28.88
Equity0000
OPM (%)36.0021.0010.0018.00
Net Profit366.18+129.5%159.55+265.2%43.69-47.6%83.34
NPM (%)27.0016.006.0013.00
EPS (Rs)44.73+124.7%19.91+67.2%11.91-47.9%22.87
CEPS44.5819.9111.9022.87

Consolidated

16 lines · 6 periods
MetricSep-26Jun-26Dec-25Sep-25Jun-25FY24-25
Revenue436.92+42.7%329.67+59.1%393.18306.20207.241,006.88
Other Income5.101.804.709.8415.9416.93
Total Income442.01+39.9%331.48+48.5%397.88316.03223.181,023.81
Interest1.021.1400.580.646.22
Expenditure-274.65-24.9%-227.57-37.9%-253.21-219.85-165-807.60
PBDT000000
EBITDA175.98+84.6%113.06+121.6%139.9795.3351.01232.12
Depreciation-12.69-9.820-8.40-8.13-26.62
EBIT163.29+87.8%103.24+140.8%139.9786.9342.88205.50
PBT167.36+74.0%103.91+78.9%144.6796.1858.08216.16
Tax-44.22-28.92-38.45-24.32-14-55.70
Equity40.9440.940000
OPM37.8631.3536.3630.4326.0221.11
Net Profit123.14+71.4%74.99+70.4%106.2271.8644.01160.42
NPM27.8622.6226.7022.7419.7215.67
EPS15.29+73.4%9.07+67.7%08.825.4119.81

Yearly results

Last 6 financial years · YoY % vs previous FY

Yearly

17 lines · 3 years
MetricFY 24-25FY 23-24FY 22-23
Revenue1,006.88+40.3%717.48+16.3%616.74
Other Income16.937.494.32
Total Income1,023.81+41.2%724.97+16.7%621.05
Expenditure-807.60-32.2%-610.98-20.1%-508.88
Interest-6.22-5.94-2.41
PBDT000
EBITDA232.12+80.6%128.50+4.8%122.61
Depreciation-26.62-16.06-12.34
EBIT205.50+82.8%112.44+2.0%110.27
PBT216.16+163.9%81.90-27.0%112.17
Tax-55.70-33.19-28.88
Equity000
OPM (%)21.1111.3018.06
Net Profit160.42+229.3%48.71-41.5%83.29
NPM (%)15.676.7213.41
EPS (Rs)19.81+69.8%11.67-49.0%22.86
CEPS19.8111.6622.86

Corporate Actions

Dividends, bonus issues, and stock splits

Dividend

4
YearTypeAmountEx-Date
2026Final Dividend2.517 Sep 2026
2025Final Dividend1.518 Sep 2025
2024Final Dividend313 Sep 2024
2023Final Dividend318 Sep 2023

Bonus

0

No bonus history.

Split

1
YearRatioEx-Date
2025Rs.10/- to Rs.5/-25 Apr 2025
Loading company dashboard...
Fetching ratios, charts, and peers